← Back to Search

Baseline followed by 5-10% THC Validation for Cannabis

Phase 1
Waitlist Available
Led By Timothy L Brown, Ph.D.
Research Sponsored by ISBRG Corp
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, 20, 30, 60, 90, 120 and 180 minutes
Awards & highlights

Study Summary

Subjects will participate in a 2-visit study protocol in which they will be administered cannabis of pre-determined concentrations and asked to complete a simulated drive in a driving simulator. Subjects will be scanned on two SpotLight-THC (Alpha and Beta iterations) devices and peripheral venous whole blood will be collected from subjects for analysis on up to four occasions on each visit. The purpose of the investigation will be to determine whether the SpotLight-THC device is a reliable measure of THC impairment at the roadside, with an objective to identify a unique blood analyte architecture for THC impairment using near infrared light and machine learning.

Eligible Conditions
  • Cannabis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, 20, 30, 60, 90, 120 and 180 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, 20, 30, 60, 90, 120 and 180 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Acute Subjective Response to Cannabis Score
Secondary outcome measures
Blood Delta-9-THC
Standard Deviation of Lateral Position (SDLP) - Distracted
Standard Deviation of Lateral Position (SDLP) - Undistracted

Trial Design

2Treatment groups
Experimental Treatment
Group I: Baseline followed by 5-10% THC VerificationExperimental Treatment1 Intervention
Group II: Baseline followed by 5-10% THC ValidationExperimental Treatment1 Intervention

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

ISBRG CorpLead Sponsor
1 Previous Clinical Trials
12,500 Total Patients Enrolled
National Advanced Driving SimulatorOTHER
Timothy L Brown, Ph.D.Principal InvestigatorNational Advanced Driving Simulator
1 Previous Clinical Trials
18 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Texas
Iowa
How old are they?
18 - 65
What site did they apply to?
National Advanced Driving Simulator
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

How responsive is this trial?

Typically responds via
Email
Recent research and studies
clinicaltrials.govStudy
Detection of Cannabis Impairment With ISBRG's SpotLight-THC
2022. "Detection of Cannabis Impairment With ISBRG's SpotLight-THC". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05276232.
~24 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top